Concepedia

Publication | Open Access

Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on <i>KRAS</i> and <i>MEK</i> Alteration Status

DOIFull Paper Access

44

Citations

8

References

2022

Year

Jithma P. Abeykoon, Karen L. Rech, Jason R. Young, Aishwarya Ravindran, Gordon Ruan, Surendra Dasari, Diana Morlote, Rebecca L. King, Claire Rummage, Saurabh Zanwar,
JAMA Oncology

Abstract

In this cohort study, treatment with cobimetinib was associated with positive outcomes in KRAS- or MEK-variant RDD. However, AEs requiring dose modifications were common.

References

YearCitations

Page 1